Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment
BACKGROUND: Hyperlipidemia secondary to protease inhibitors (PI) may abate by switching to anti-HIV medications without lipid effects. METHOD: An open-label, randomized pilot study compared changes in fasting lipids and HIV-1 RNA in 104 HIV-infected adults with PI-associated hyperlipidemia (fasting...
Na minha lista:
| Publicado no: | BMC Infect Dis |
|---|---|
| Principais autores: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC548524/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15647105/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2334-5-2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
